HLA-C and COVID-19: This study described a biologically plausible potential association of HLA-C*04:01 with severe clinical course of COVID-19, as HLA-C*04:01 has fewer predicted binding sites for relevant SARS-CoV-2 peptides compared to other HLA alleles.